Want to see KZIA full AI Analyst Report?
Kazia Therapeutics (KZIA) Ratios
Kazia Therapeutics Ratios
KZIA's free cash flow for Q2 2026 was $-9.07M. For the 2026 fiscal year, KZIA's free cash flow was increased by $6.00 and operating cash flow was $-9.07M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.35 | 0.24 | 1.42 | 1.40 | 3.53 |
| Quick Ratio | 0.35 | 0.24 | 1.42 | 1.40 | 3.53 |
| Cash Ratio | 0.31 | 0.06 | 0.69 | 1.09 | 3.31 |
| Solvency Ratio | -1.38 | -0.79 | -1.16 | -1.31 | -0.35 |
| Operating Cash Flow Ratio | -0.94 | -0.37 | -2.00 | -3.38 | -1.09 |
| Short-Term Operating Cash Flow Coverage | -33.53 | -15.11 | -8.44 | -12.36 | 0.00 |
| Net Current Asset Value | $ -9.43M | $ -25.46M | $ -5.26M | $ -8.16M | $ 9.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.03 | 0.06 | 0.05 | 0.00 |
| Debt-to-Equity Ratio | -0.05 | -0.06 | 0.15 | 0.10 | 0.00 |
| Debt-to-Capital Ratio | -0.05 | -0.07 | 0.13 | 0.09 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.73 | -2.15 | 2.33 | 1.96 | 1.53 |
| Debt Service Coverage Ratio | -29.13 | -41.52 | -12.25 | -12.56 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -12129.42 | 0.00 |
| Debt to Market Cap | 0.04 | 0.08 | 0.06 | 0.02 | 0.00 |
| Interest Debt Per Share | 0.36 | 1.32 | 4.87 | 6.96 | 0.00 |
| Net Debt to EBITDA | 0.30 | 0.04 | 0.15 | 0.23 | 5.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -33850.00% | -1233.19% | -4350725.59% | -253840.00% | -41.99% |
| EBITDA Margin | -31626.19% | -1152.21% | -4013885.95% | -235150.00% | -33.66% |
| Operating Profit Margin | -33850.00% | -1233.19% | -4346661.08% | -253990.00% | -41.99% |
| Pretax Profit Margin | -53447.62% | -1171.97% | -3736265.23% | -253820.00% | -58.64% |
| Net Profit Margin | -49290.48% | -1160.23% | -3687419.82% | -250140.00% | -55.46% |
| Continuous Operations Profit Margin | -49290.48% | -1160.23% | -3687419.82% | -250140.00% | -55.46% |
| Net Income Per EBT | 92.22% | 99.00% | 98.69% | 98.55% | 94.56% |
| EBT Per EBIT | 157.90% | 95.04% | 85.96% | 99.93% | 139.65% |
| Return on Assets (ROA) | -341.56% | -124.06% | -72.87% | -69.70% | -14.50% |
| Return on Equity (ROE) | 249.39% | 267.33% | -169.84% | -136.88% | -22.25% |
| Return on Capital Employed (ROCE) | 177.89% | 675.74% | -117.57% | -87.10% | -12.81% |
| Return on Invested Capital (ROIC) | 172.61% | 787.50% | -106.69% | -80.74% | -12.12% |
| Return on Tangible Assets | -416.20% | -432.95% | -189.23% | -149.34% | -23.33% |
| Earnings Yield | -198.39% | -342.80% | -63.79% | -31.03% | -5.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.47 | 17.35 | 0.01 | 0.20 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.01 | 0.11 | 0.00 | 0.00 | 0.26 |
| Working Capital Turnover Ratio | -0.00 | -0.28 | 0.00 | 0.00 | 1.14 |
| Cash Conversion Cycle | 782.14 | 21.03 | 69054.05 | 1861.50 | 0.00 |
| Days of Sales Outstanding | 782.14 | 21.03 | 69054.05 | 1861.50 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 782.14 | 21.03 | 69054.05 | 1861.50 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -12.12 | -19.98 | -41.12 | -85.89 | -38.70 |
| Free Cash Flow Per Share | -12.12 | -19.98 | -41.12 | -85.89 | -38.70 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -33.53 | -15.11 | -8.44 | -12.36 | 0.00 |
| Operating Cash Flow to Sales Ratio | -316.14 | -4.15 | -27308.11 | -2276.20 | -0.60 |
| Free Cash Flow Yield | -127.25% | -122.65% | -47.24% | -28.24% | -5.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.50 | -0.29 | -1.57 | -3.22 | -18.37 |
| Price-to-Sales (P/S) Ratio | 248.45 | 3.38 | 57807.50 | 8060.35 | 10.19 |
| Price-to-Book (P/B) Ratio | -1.26 | -0.78 | 2.66 | 4.41 | 4.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.79 | -0.82 | -2.12 | -3.54 | -16.98 |
| Price-to-Operating Cash Flow Ratio | -0.79 | -0.82 | -2.12 | -3.54 | -16.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.00 | 0.04 | -0.02 | 0.33 |
| Enterprise Value Multiple | -0.49 | -0.26 | -1.29 | -3.19 | -24.87 |
| Enterprise Value | 6.49M | 6.79M | 28.64M | 75.08M | 127.10M |
| EV to EBITDA | -0.49 | -0.26 | -1.29 | -3.19 | -24.87 |
| EV to Sales | 154.43 | 2.94 | 51600.30 | 7508.35 | 8.37 |
| EV to Free Cash Flow | -0.49 | -0.71 | -1.89 | -3.30 | -13.95 |
| EV to Operating Cash Flow | -0.49 | -0.71 | -1.89 | -3.30 | -13.95 |
| Tangible Book Value Per Share | -8.57 | -53.00 | -14.16 | -3.26 | 67.32 |
| Shareholders’ Equity Per Share | -7.58 | -20.89 | 32.69 | 68.96 | 160.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.01 | 0.01 | 0.01 | 0.05 |
| Revenue Per Share | 0.04 | 4.81 | 0.00 | 0.04 | 64.50 |
| Net Income Per Share | -18.90 | -55.83 | -55.52 | -94.39 | -35.77 |
| Tax Burden | 0.92 | 0.99 | 0.99 | 0.99 | 0.95 |
| Interest Burden | 1.58 | 0.95 | 0.86 | 1.00 | 1.40 |
| Research & Development to Revenue | 174.43 | 7.53 | 28043.37 | 2016.90 | 0.96 |
| SG&A to Revenue | 207.62 | 5.88 | 15464.89 | 511.30 | 0.46 |
| Stock-Based Compensation to Revenue | 15.55 | 0.23 | 2088.29 | 167.50 | 0.04 |
| Income Quality | 0.64 | 0.36 | 0.74 | 0.91 | 1.08 |
Currency in AUD
